| __timestamp | Agios Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 2242216 |
| Thursday, January 1, 2015 | 141827000 | 4536244 |
| Friday, January 1, 2016 | 220163000 | 5184803 |
| Sunday, January 1, 2017 | 292681000 | 3068742 |
| Monday, January 1, 2018 | 341324000 | 7178000 |
| Tuesday, January 1, 2019 | 410894000 | 16267000 |
| Wednesday, January 1, 2020 | 367470000 | 23191000 |
| Friday, January 1, 2021 | 256973000 | 21453000 |
| Saturday, January 1, 2022 | 279910000 | 15265000 |
| Sunday, January 1, 2023 | 288903000 | 25189000 |
| Monday, January 1, 2024 | 301286000 |
Data in motion
In the competitive world of biotechnology, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Agios Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to R&D spending.
From 2014 to 2023, Agios Pharmaceuticals has consistently prioritized R&D, with expenditures peaking in 2019 at approximately 41% higher than their 2014 levels. This commitment underscores their dedication to pioneering new therapies and maintaining a competitive edge.
In contrast, Soleno Therapeutics has shown a steady increase in R&D spending, with a notable 102% rise from 2014 to 2023. This growth reflects their strategic focus on expanding their therapeutic pipeline and enhancing their market presence.
Both companies exemplify the critical role of R&D in driving innovation and long-term success in the biotech industry.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Agios Pharmaceuticals, Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.